![Alexandra Dambeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexandra Dambeck
Direttore Finanziario/CFO presso
SPRINGER NATURE AG & CO. KGAA
Profilo
Alexandra Dambeck currently works at Springer Nature AG & Co. KGaA, as Chief Financial Officer.
Ms. Dambeck also formerly worked at Fresenius Medical Care Ventures GmbH, as Managing Director from 2016 to 2020 and Fresenius Medical Care AG, as Head-Corporate Controlling & Corporate Accounting.
Posizioni attive di Alexandra Dambeck
| Società | Posizione | Inizio |
|---|---|---|
| SPRINGER NATURE AG & CO. KGAA | Direttore Finanziario/CFO | - |
Precedenti posizioni note di Alexandra Dambeck
| Società | Posizione | Fine |
|---|---|---|
Fresenius Medical Care Ventures GmbH
 Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Direttore/Membro del Consiglio | 31/12/2020 |
| FRESENIUS MEDICAL CARE AG | Comptroller/Controller/Auditor | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
4
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Fresenius Medical Care AG
 Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products | Health Services |
Fresenius Medical Care Ventures GmbH
Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Finance |
Springer Nature AG & Co. KGaA
 Springer Nature AG & Co. KGaA Publishing: Books/MagazinesConsumer Services Publishes trade journals | Consumer Services |
